NCT00025285View on ClinicalTrials.gov

Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 1, 2001

Primary Completion Date

September 29, 2004

Study Completion Date

September 29, 2004

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

irinotecan hydrochloride

DRUG

thalidomide

Trial Locations (5)

29303

CCOP - Upstate Carolina, Spartanburg

29615

CCOP - Greenville, Greenville

62526

CCOP - Central Illinois, Decatur

27534-9479

Southeastern Medical Oncology Center, Goldsboro

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00025285 - Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter